Clinical Trial Update: Evaluation of a Preventive Therapeutic Strategy for Postpartum Venous Thromboembolism in Women With Genetic Risk Factor

View source ↗

Summary

A completed clinical trial evaluated a preventive therapy for postpartum venous thromboembolism in women with genetic risk factors (Factor V Leiden or Factor II…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Venous Thromboembolism
• Venous Thromboembolism

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Factor V Leiden Heterozygous Mutation, Factor II Heterozygous Mutation | Status: COMPLETED